Intellectus Partners’s Nuvation Bio NUVB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $1.25M | Buy |
290,417
+5,000
| +2% | +$27.9K | 0.25% | 111 |
|
|
2025
Q4 | $2.56M | Sell |
285,417
-46,388
| -14% | -$287K | 0.49% | 49 |
|
|
2025
Q3 | $1.23M | Buy |
331,805
+2,000
| +0.6% | +$5.45K | 0.24% | 110 |
|
|
2025
Q2 | $643K | Buy |
329,805
+8,900
| +3% | +$18.5K | 0.14% | 174 |
|
|
2025
Q1 | $565K | Buy |
320,905
+40,000
| +14% | +$91.1K | 0.14% | 179 |
|
|
2024
Q4 | $747K | Buy |
280,905
+19,500
| +7% | +$50.2K | 0.17% | 159 |
|
|
2024
Q3 | $599K | Buy |
261,405
+14,500
| +6% | +$44.2K | 0.15% | 175 |
|
|
2024
Q2 | $721K | Buy |
246,905
+12,465
| +5% | +$38K | 0.2% | 143 |
|
|
2024
Q1 | $853K | Buy |
234,440
+53,318
| +29% | +$102K | 0.22% | 128 |
|
|
2023
Q4 | $273K | Sell |
181,122
-19,105
| -10% | -$24.6K | 0.08% | 210 |
|
|
2023
Q3 | $268K | Buy |
200,227
+698
| +0.3% | +$1.16K | 0.08% | 213 |
|
|
2023
Q2 | $359K | Buy |
199,529
+17,860
| +10% | +$30.4K | 0.11% | 203 |
|
|
2023
Q1 | $302K | Sell |
181,669
-1,500
| -0.8% | -$3.04K | 0.1% | 203 |
|
|
2022
Q4 | $352K | Buy |
183,169
+9,223
| +5% | +$18.7K | 0.12% | 194 |
|
|
2022
Q3 | $390K | Buy |
173,946
+12,680
| +8% | +$36.2K | 0.14% | 180 |
|
|
2022
Q2 | $523K | Buy |
161,266
+12,192
| +8% | +$53.2K | 0.18% | 158 |
|
|
2022
Q1 | $784K | Buy |
149,074
+8,752
| +6% | +$49.2K | 0.23% | 110 |
|
|
2021
Q4 | $1.19M | Sell |
140,322
-14,105
| -9% | -$130K | 0.3% | 86 |
|
|
2021
Q3 | $1.53M | Buy |
154,427
+33,995
| +28% | +$308K | 0.37% | 71 |
|
|
2021
Q2 | $1.12M | Buy |
120,432
+21,008
| +21% | +$240K | 0.25% | 109 |
|
|
2021
Q1 | $1.04M | Sell |
99,424
-32,520
| -25% | -$364K | 0.29% | 109 |
|
|
2020
Q4 | $1.54M | Buy |
+131,944
| New | +$1.37M | 0.46% | 62 |
|
Other funds holding NUVB
DC
VCM
OFM
LCM
DFO
